Sagimet Biosciences Inc - Ordinary Shares - Class A

Sagimet Biosciences Inc - Ordinary Shares - Class A

SGMT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$530.61M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sagimet Biosciences Inc - Ordinary Shares - Class ASagimet Biosciences Inc - Ordinary Shares - Class A-7.7--18%--
$20.00

Target Price by Analysts

100.2% upsideSagimet Biosciences Target Price DetailsTarget Price
$1.08

Current Fair Value

89.2% downside

Overvalued by 89.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$530.61 Million
Enterprise Value$366.66 Million
Earnings per Share$-1.58
Beta3.49
Outstanding Shares53,114,533

Return

Return on Equity-18.38%ROE
Return on Assets-17.87%
Return on Invested Capital-19.68%

Valuation & Multiples

P/E Ratio-7.75P/E Ratio
PEG-22.57PEG
Price to Sales-Price to Sales
Price to Book Ratio2.5Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-7.22
Enterprise Value to Net Income-8
Total Debt to Enterprise0.01
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 19, 2026
EPS Estimate
$-0.33
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
November 12, 2026
EPS Estimate
$-0.25
Consensus analyst estimate
Revenue Estimate
$166,667
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 105.12%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.13%▼ 96.24%
Total Invested$693,562▼ 99.82%
Investors Holding10▼ 120.00%

About Sagimet Biosciences Inc

in march of 1963, a one-man pool supply operation working out of a backyard shed in north hollywood, california, began. that journey continues today - 50 years later - as leslie's poolmart, inc., “the world’s largest retailer of swimming...

Sagimet Biosciences Insider Information FAQ

Stockcircle tracks 3 top investors with a current 13F position in Sagimet Biosciences. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 5 open-market insider sales for Sagimet Biosciences in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.